{
    "info": {
        "nct_id": "NCT05349643",
        "official_title": "A Phase 2, Open-Label, Adaptive, Dose-Ranging Study With Long-Term Extension to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Intra Articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor",
        "inclusion_criteria": "1. Subject ≥ 18 years\n2. TGCT with only 1 joint involvement\n3. Symptomatic Measurable disease of at least 1 cm based on RECIST v1.1\n4. Stable prescription of analgesic regimen\n5. Agrees to follow contraception guidelines\n6. Women of childbearing potential must have a negative pregnancy test\n7. Adequate hematologic, hepatic, and renal function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Prior investigational drug use within 4 weeks or 5 half-lives of Baseline\n2. Previous use of therapeutics targeting CSF1 or CSF1R or oral tyrosine kinase inhibitors within 3 months prior to Baseline\n3. History of extensive or reconstructive surgery on the affected joint\n4. Active cancer (either currently or within 3 mo before Baseline) that requires/required therapy (e.g., surgery, chemotherapy, or radiation therapy)\n5. Metastatic or malignant transformation of TGCT\n6. Hepatitis C virus (HCV) or hepatitis B virus (HBV) or human immunodeficiency virus (HIV)\n7. Known active tuberculosis\n8. Significant concomitant arthropathy in the affected joint, serious illness, uncontrolled infection, or a medical or psychiatric history\n9. Women who are breastfeeding\n10. A screening Fridericia-corrected QT interval (QTcF) ≥ 470 ms\n11. MRI contraindications (e.g., pacemaker, loose metallic implants)\n12. History of hypersensitivity to any ingredient of the study drug\n13. History of drug or alcohol abuse within 3 months before baseline\n14. Any other severe acute or chronic medical or psychiatric condition or clinically significant laboratory abnormality that may increase the risk associated with study participation/treatment or interfere with interpretation of study results and, in the Investigator's opinion, make the subject inappropriate for this study\n15. Subjects who, in the Investigator's opinion, should not participate in the study for any reason, including if there is a question about their ability to comply with study requirements",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "4. Stable prescription of analgesic regimen",
            "criterions": [
                {
                    "exact_snippets": "Stable prescription of analgesic regimen",
                    "criterion": "analgesic regimen prescription",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. TGCT with only 1 joint involvement",
            "criterions": [
                {
                    "exact_snippets": "TGCT",
                    "criterion": "TGCT",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "only 1 joint involvement",
                    "criterion": "joint involvement",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "=",
                                "value": 1,
                                "unit": "joint"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Subject ≥ 18 years",
            "criterions": [
                {
                    "exact_snippets": "Subject ≥ 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Symptomatic Measurable disease of at least 1 cm based on RECIST v1.1",
            "criterions": [
                {
                    "exact_snippets": "Symptomatic Measurable disease",
                    "criterion": "measurable disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "at least 1 cm",
                    "criterion": "measurable disease size",
                    "requirements": [
                        {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "cm"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "based on RECIST v1.1",
                    "criterion": "measurable disease assessment method",
                    "requirements": [
                        {
                            "requirement_type": "assessment method",
                            "expected_value": "RECIST v1.1"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Agrees to follow contraception guidelines",
            "criterions": [
                {
                    "exact_snippets": "Agrees to follow contraception guidelines",
                    "criterion": "contraception guideline adherence",
                    "requirements": [
                        {
                            "requirement_type": "agreement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Women of childbearing potential must have a negative pregnancy test",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential",
                    "criterion": "sex and reproductive status",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive status",
                            "expected_value": "childbearing potential"
                        }
                    ]
                },
                {
                    "exact_snippets": "must have a negative pregnancy test",
                    "criterion": "pregnancy test result",
                    "requirements": [
                        {
                            "requirement_type": "test result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Adequate hematologic, hepatic, and renal function",
            "criterions": [
                {
                    "exact_snippets": "Adequate hematologic ... function",
                    "criterion": "hematologic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... hepatic ... function",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate ... renal function",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "4. Active cancer (either currently or within 3 mo before Baseline) that requires/required therapy (e.g., surgery, chemotherapy, or radiation therapy)",
            "criterions": [
                {
                    "exact_snippets": "Active cancer (either currently or within 3 mo before Baseline)",
                    "criterion": "active cancer",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "requires/required therapy (e.g., surgery, chemotherapy, or radiation therapy)",
                    "criterion": "cancer therapy requirement",
                    "requirements": [
                        {
                            "requirement_type": "requirement for therapy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "therapy types",
                            "expected_value": [
                                "surgery",
                                "chemotherapy",
                                "radiation therapy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Previous use of therapeutics targeting CSF1 or CSF1R or oral tyrosine kinase inhibitors within 3 months prior to Baseline",
            "criterions": [
                {
                    "exact_snippets": "Previous use of therapeutics targeting CSF1 or CSF1R ... within 3 months prior to Baseline",
                    "criterion": "use of therapeutics targeting CSF1 or CSF1R",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months prior to Baseline"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Previous use of ... oral tyrosine kinase inhibitors within 3 months prior to Baseline",
                    "criterion": "use of oral tyrosine kinase inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months prior to Baseline"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Metastatic or malignant transformation of TGCT",
            "criterions": [
                {
                    "exact_snippets": "Metastatic ... TGCT",
                    "criterion": "TGCT",
                    "requirements": [
                        {
                            "requirement_type": "metastatic",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "malignant transformation of TGCT",
                    "criterion": "TGCT",
                    "requirements": [
                        {
                            "requirement_type": "malignant transformation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. A screening Fridericia-corrected QT interval (QTcF) ≥ 470 ms",
            "criterions": [
                {
                    "exact_snippets": "A screening Fridericia-corrected QT interval (QTcF) ≥ 470 ms",
                    "criterion": "Fridericia-corrected QT interval (QTcF)",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 470,
                                "unit": "ms"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Women who are breastfeeding",
            "criterions": [
                {
                    "exact_snippets": "Women who are breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "breastfeeding"
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. History of extensive or reconstructive surgery on the affected joint",
            "criterions": [
                {
                    "exact_snippets": "History of extensive or reconstructive surgery on the affected joint",
                    "criterion": "surgery on the affected joint",
                    "requirements": [
                        {
                            "requirement_type": "history of extensive surgery",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "history of reconstructive surgery",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. MRI contraindications (e.g., pacemaker, loose metallic implants)",
            "criterions": [
                {
                    "exact_snippets": "MRI contraindications",
                    "criterion": "MRI contraindications",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "pacemaker",
                    "criterion": "pacemaker",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "loose metallic implants",
                    "criterion": "loose metallic implants",
                    "requirements": [
                        {
                            "requirement_type": "absence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Known active tuberculosis",
            "criterions": [
                {
                    "exact_snippets": "Known active tuberculosis",
                    "criterion": "tuberculosis",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "awareness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. History of hypersensitivity to any ingredient of the study drug",
            "criterions": [
                {
                    "exact_snippets": "History of hypersensitivity to any ingredient of the study drug",
                    "criterion": "hypersensitivity to any ingredient of the study drug",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Prior investigational drug use within 4 weeks or 5 half-lives of Baseline",
            "criterions": [
                {
                    "exact_snippets": "Prior investigational drug use within 4 weeks or 5 half-lives of Baseline",
                    "criterion": "prior investigational drug use",
                    "requirements": [
                        {
                            "requirement_type": "time since last use",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 4,
                                        "unit": "weeks"
                                    },
                                    {
                                        "operator": ">=",
                                        "value": 5,
                                        "unit": "half-lives"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "15. Subjects who, in the Investigator's opinion, should not participate in the study for any reason, including if there is a question about their ability to comply with study requirements",
            "criterions": [
                {
                    "exact_snippets": "Subjects who, in the Investigator's opinion, should not participate in the study for any reason",
                    "criterion": "Investigator's opinion regarding participation",
                    "requirements": [
                        {
                            "requirement_type": "approval",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "if there is a question about their ability to comply with study requirements",
                    "criterion": "ability to comply with study requirements",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Significant concomitant arthropathy in the affected joint, serious illness, uncontrolled infection, or a medical or psychiatric history",
            "criterions": [
                {
                    "exact_snippets": "Significant concomitant arthropathy in the affected joint",
                    "criterion": "arthropathy in the affected joint",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        },
                        {
                            "requirement_type": "concomitance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "serious illness",
                    "criterion": "illness",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "serious"
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "control",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "medical or psychiatric history",
                    "criterion": "medical or psychiatric history",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "13. History of drug or alcohol abuse within 3 months before baseline",
            "criterions": [
                {
                    "exact_snippets": "History of drug or alcohol abuse within 3 months before baseline",
                    "criterion": "drug abuse",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months before baseline"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "History of drug or alcohol abuse within 3 months before baseline",
                    "criterion": "alcohol abuse",
                    "requirements": [
                        {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months before baseline"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "14. Any other severe acute or chronic medical or psychiatric condition or clinically significant laboratory abnormality that may increase the risk associated with study participation/treatment or interfere with interpretation of study results and, in the Investigator's opinion, make the subject inappropriate for this study",
            "criterions": [
                {
                    "exact_snippets": "Any other severe acute or chronic medical or psychiatric condition",
                    "criterion": "medical or psychiatric condition",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": "severe"
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": [
                                "acute",
                                "chronic"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "clinically significant laboratory abnormality",
                    "criterion": "laboratory abnormality",
                    "requirements": [
                        {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "that may increase the risk associated with study participation/treatment or interfere with interpretation of study results and, in the Investigator's opinion, make the subject inappropriate for this study",
                    "criterion": "risk of study participation or interference with study results (per Investigator's opinion)",
                    "requirements": [
                        {
                            "requirement_type": "investigator judgment",
                            "expected_value": "subject inappropriate for study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Hepatitis C virus (HCV) or hepatitis B virus (HBV) or human immunodeficiency virus (HIV)",
            "criterions": [
                {
                    "exact_snippets": "Hepatitis C virus (HCV)",
                    "criterion": "Hepatitis C virus infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "hepatitis B virus (HBV)",
                    "criterion": "Hepatitis B virus infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "human immunodeficiency virus (HIV)",
                    "criterion": "Human immunodeficiency virus infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}